Both in Pharmaceuticals
Organogenesis Holdings vs Anixa Biosciences
Over the past year ORGO returned −77.6% and ANIX returned −17.4%; their daily moves had a correlation of 0.12.
ORGO −77.6% ANIX −17.4%Growth of $1, one year, split-adjusted
| Metric | ORGO | ANIX |
|---|---|---|
| Price | $0.8700 | $3.28 |
| Market cap | $111.9M | $114.0M |
| Today | +4.19% | +7.37% |
| 1 month | −35.1% | +8.6% |
| 6 months | −66.0% | +7.2% |
| Year to date | −83.2% | +5.1% |
| 1 year | −78.3% | −20.8% |
| Revenue growth (YoY) | −56.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −227.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | $34.4M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 61.2% | 60.6% |
| Short % of float | 21.7% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).